Healthcare Sector Articles Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame Keywords May 12, 2026 11:00 AM ETHims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?Jessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?May 10, 2026 6:50 AM ET3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillChris MarkochNYSE:UNHNYSE:HUMNYSE:CVSRead 3 Healthcare Stocks Set to Benefit From the One Big Beautiful BillMay 8, 2026 9:10 AM ETHims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusJessica MitacekNYSE:HIMSNYSE:NVORead Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in FocusMay 7, 2026 8:05 AM ETWhat the FDA's Latest Proposal Means for Lilly, Novo, and HimsLeo MillerNYSE:LLYNYSE:NVONYSE:HIMSRead What the FDA's Latest Proposal Means for Lilly, Novo, and HimsMay 5, 2026 10:25 AM ET3 Reasons Analysts Love DexComNathan ReiffNASDAQ:DXCMNYSE:MDTRead 3 Reasons Analysts Love DexComMay 2, 2026 6:45 AM ETThe Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatJessica MitacekNYSE:ABBVNYSE:AZNNYSE:GSKRead The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the BeatMay 1, 2026 11:05 AM ETLilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentNathan ReiffNYSE:LLYNYSE:NVORead Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It PermanentMay 1, 2026 8:45 AM ETViking Therapeutics Faces Timeline Risk—But Upside Could Be HugeChris MarkochNASDAQ:VKTXNYSE:LLYNYSE:NVORead Viking Therapeutics Faces Timeline Risk—But Upside Could Be HugeApril 29, 2026 12:50 PM ETAbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?Thomas HughesNYSE:ABBVNYSE:ABTRead AbbVie Fires Healthy Trend-Following Signal: Is a Rebound Ahead?April 28, 2026 7:55 AM ETAmazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansLeo MillerNYSE:HIMSNYSE:LLYNYSE:NVORead Amazon Takes a Bite Out of Hims: What Its GLP-1 Entrance MeansApril 27, 2026 9:15 AM ETThese 3 Psychedelic Stocks Activated After Trump's Executive OrderNathan ReiffNASDAQ:CMPSNASDAQ:ATAINASDAQ:MNMDRead These 3 Psychedelic Stocks Activated After Trump's Executive OrderApril 27, 2026 5:05 AM ET3 Biotech Stocks That Could Benefit from the Patent CliffChris MarkochNASDAQ:NTLANASDAQ:BEAMNASDAQ:CRSPRead 3 Biotech Stocks That Could Benefit from the Patent CliffApril 23, 2026 12:40 PM ETThe Cannabis Sector's Billion-Dollar Tax CutJeffrey Neal JohnsonOTCMKTS:GTBIFOTCMKTS:CURLFOTCMKTS:TCNNFRead The Cannabis Sector's Billion-Dollar Tax CutApril 23, 2026 8:00 AM ETIntuitive Surgical's Selloff Sets Up a 30% Rebound OpportunityThomas HughesNASDAQ:ISRGNYSE:MDTRead Intuitive Surgical's Selloff Sets Up a 30% Rebound OpportunityApril 21, 2026 10:25 AM ETA Healthy Rebound Could Lie Ahead for UNH ShareholdersThomas HughesNYSE:UNHRead A Healthy Rebound Could Lie Ahead for UNH ShareholdersApril 20, 2026 1:05 PM ETThis 4/20, Wall Street Is Betting on More Than MarijuanaJeffrey Neal JohnsonNASDAQ:CMPSNASDAQ:ATAINYSEARCA:MSOSRead This 4/20, Wall Street Is Betting on More Than MarijuanaApril 17, 2026 8:45 AM ETAbbott Stock Crash: Rebound Could Be Coming FastThomas HughesNYSE:ABTRead Abbott Stock Crash: Rebound Could Be Coming FastApril 14, 2026 12:10 PM ETJohnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings ResultsThomas HughesNYSE:JNJRead Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings ResultsApril 13, 2026 7:40 AM ET3 Oversold Healthcare Stocks to Buy After Jobs DataChris MarkochNYSE:UHSRead 3 Oversold Healthcare Stocks to Buy After Jobs DataApril 9, 2026 12:00 PM ET3 Dividend Aristocrats Whose Yields Can Help Combat InflationChris MarkochNYSE:AMCRNYSE:CVXNYSE:ABBVRead 3 Dividend Aristocrats Whose Yields Can Help Combat InflationApril 7, 2026 10:45 AM ETA Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?Jeffrey Neal JohnsonNYSE:ABTRead A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?April 2, 2026 10:15 AM ETLilly's Next Empire: A $10 Billion Bet on AI and NeuroscienceJeffrey Neal JohnsonNYSE:LLYRead Lilly's Next Empire: A $10 Billion Bet on AI and NeuroscienceApril 2, 2026 6:55 AM ETPhreesia Hits Bottom in Q1: Rebound Ahead, Timing UncertainThomas HughesNYSE:PHRRead Phreesia Hits Bottom in Q1: Rebound Ahead, Timing UncertainMarch 31, 2026 5:58 AM ETMerck Just Made a Big Bet on a New Cancer Growth Engine Jessica MitacekNYSE:MRKNYSE:LLYNYSE:ABBVRead Merck Just Made a Big Bet on a New Cancer Growth Engine March 29, 2026 7:07 AM ETThe Often-Missed Corner of Healthcare That Wall Street Is LovingNathan ReiffNYSE:TMONYSE:DHRNYSE:ARead The Often-Missed Corner of Healthcare That Wall Street Is LovingMarch 24, 2026 2:15 PM ETWhy Boston Scientific's Big Dip Could Be a Bigger OpportunityNathan ReiffNYSE:BSXRead Why Boston Scientific's Big Dip Could Be a Bigger OpportunityMarch 16, 2026 5:44 AM ET3 Companies at the Forefront of the GLP-1 Pill WarsNathan ReiffNYSE:LLYNASDAQ:VKTXNASDAQ:GPCRRead 3 Companies at the Forefront of the GLP-1 Pill WarsMarch 15, 2026 8:05 AM ET3 Stocks That Could Be Next to Announce a Stock SplitChris MarkochNASDAQ:KLACNYSE:LLYNYSE:MCKRead 3 Stocks That Could Be Next to Announce a Stock SplitMarch 15, 2026 6:19 AM ETEli Lilly’s Employer Push Could Unlock New GLP-1 DemandLeo MillerNYSE:LLYNYSE:NVORead Eli Lilly’s Employer Push Could Unlock New GLP-1 DemandMarch 13, 2026 10:22 AM ETThe Real Reason Eli Lilly Is Pouring $3 Billion Into ChinaJeffrey Neal JohnsonNYSE:LLYNYSE:NVORead The Real Reason Eli Lilly Is Pouring $3 Billion Into China Page 1 of 2 12 Earlier › More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
